Thursday, October 12, 2017 10:15 PM ET
Insider at KalVista Pharmaceuticals (KALV) Makes Significant Sale of Stock
There was a significant sale of shares of KalVista Pharmaceuticals by an insider today, as indicated in a form 4 document filed with the SEC. One insider — Novo A/S, 10% Owner — disposed of 2,725,283 shares in the company having a market value of approximately $26,271,182. There was one insider buy/sell transaction in the past 90 days prior to this transaction which resulted in the sale of 176,647 shares. Adding the most recent activity to this 90-day history indicates insider trades have been net sales of 2,901,930 shares and have averaged 1,450,965 shares per transaction over this time period.
Insiders at KalVista Pharmaceuticals have a higher number of buy/sell transactions than the 42-peer company average over the last 90-day period. The Biopharmaceuticals peer group saw 25 buy/sell trades during this period for an average of 0.6 transactions per company. The number of shares per buy/sell trade for KalVista Pharmaceuticals insiders was also higher. Within the peer group there were 44,500 shares purchased and 989,542 shares sold with company insiders selling 37,802 shares on average.
Insider buying and selling activity that is significant has been determined by eliminating all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers in evaluating and writing this story.
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at firstname.lastname@example.org. Copyright 2017 UpTick Data Technologies. All rights reserved.